Drugs / Next Generation Emulsion
last change Nov 2011 re-read 2 minutes ago

Next Generation Emulsion

also known as 9963X
Developed for
dry eye syndrome
Investigated by
Allergan · Glasgow Caledonian University

Trials 1 · a red edge is where a trial was stopped

2012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
NCT01384851 Jul → Nov 2011 dry eye syndrome Glasgow Caledonian University Unknown No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Next Generation Emulsion ClinicalTrials.gov intervention name — accepted as the source's own label NCT01384851
Known as 9963X “Next Generation Emulsion Multi-Dose Eye Drop (9963X) is a sterile, buffered, aqueous and emulsion topical ophthalmic product formulated for the relief of ocular surface...” NCT01384851
Route Topical “Next Generation Emulsion Multi-Dose Eye Drop (9963X) is a sterile, buffered, aqueous and emulsion topical ophthalmic product formulated for the relief of ocular surface...” NCT01384851